Figure 1

Figure 1

A single IV dose of ENTR-601-44 resulted in robust exon skipping in both skeletal and cardiac muscles in NHP, as well as prolonged duration of effect for at least 12 weeks

Format

JPEG

Quelle:

Entrada Therapeutics, Inc.

Downloads